Editorial & Columns Patent Expiry & Innovator Pharmaceutical Companies : Mechanisms applied to preserve market dominance April 24, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns India’s exports peak as global challenges loom April 20, 2024 | Abdul Wasey | No Comments | More
Editorial & Columns Saudis Arabia’s Financial and Strategic Ties with India-Pakistan Discourages Tehran April 19, 2024 | Gopal Misra | No Comments | More
Editorial & Columns Drivers of Business Growth : Evidence from Indian Pharmaceutical Industry April 18, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Electoral bonds expose flaws in political funding April 13, 2024 | Abdul Wasey | No Comments | More
Editorial & Columns Prescription for Segment Reporting by Pharmaceutical Companies in India April 13, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns India’s economy is at risk amidst fiscal strains April 6, 2024 | Abdul Wasey | No Comments | More
Editorial & Columns Foreign Direct Investment and Pharmaceutical Industry in India April 5, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Initiative to maintain balance between inflation and development April 5, 2024 | Satish Singh | No Comments | More